Cargando…

Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka

BACKGROUND: Prescription writing is a process which transfers the therapeutic message from the prescriber to the patient through the pharmacist. Prescribing errors, drug duplication and potential drug-drug interactions (pDDI) in prescriptions lead to medication error. Assessment of the above was mad...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathish, Devarajan, Bahini, Sivaswamy, Sivakumar, Thanikai, Thiranagama, Thilani, Abarajithan, Tharmarajah, Wijerathne, Buddhika, Jayasumana, Channa, Siribaddana, Sisira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921016/
https://www.ncbi.nlm.nih.gov/pubmed/27342193
http://dx.doi.org/10.1186/s40360-016-0071-z
_version_ 1782439464428109824
author Rathish, Devarajan
Bahini, Sivaswamy
Sivakumar, Thanikai
Thiranagama, Thilani
Abarajithan, Tharmarajah
Wijerathne, Buddhika
Jayasumana, Channa
Siribaddana, Sisira
author_facet Rathish, Devarajan
Bahini, Sivaswamy
Sivakumar, Thanikai
Thiranagama, Thilani
Abarajithan, Tharmarajah
Wijerathne, Buddhika
Jayasumana, Channa
Siribaddana, Sisira
author_sort Rathish, Devarajan
collection PubMed
description BACKGROUND: Prescription writing is a process which transfers the therapeutic message from the prescriber to the patient through the pharmacist. Prescribing errors, drug duplication and potential drug-drug interactions (pDDI) in prescriptions lead to medication error. Assessment of the above was made in prescriptions dispensed at State Pharmaceutical Corporation (SPC), Anuradhapura, Sri Lanka. METHODS: A cross sectional study was conducted. Drugs were classified according to the WHO anatomical, therapeutic chemical classification system. A three point Likert scale, a checklist and Medscape online drug interaction checker were used to assess legibility, completeness and pDDIs respectively. RESULTS: Thousand prescriptions were collected. Majority were hand written (99.8 %) and from the private sector (73 %). The most frequently prescribed substance and subgroup were atorvastatin (4 %, n = 3668) and proton pump inhibitors (7 %, n = 3668) respectively. Out of the substances prescribed from the government and private sectors, 59 and 50 % respectively were available in the national list of essential medicines, Sri Lanka. Patients address (5 %), Sri Lanka Medical Council (SLMC) registration number (35 %), route (7 %), generic name (16 %), treatment symbol (48 %), diagnosis (41 %) and refill information (6 %) were seen in less than half of the prescriptions. Most were legible with effort (65 %) and illegibility was seen in 9 %. There was significant difference in omission and/or errors of generic name (P = 0.000), dose (P = 0.000), SLMC registration number (P = 0.000), and in evidence of pDDI (P = 0.009) with regards to the sector of prescribing. The commonest subgroup involved in duplication was non-steroidal anti-inflammatory drugs (NSAIDs) (43 %; 56/130). There were 1376 potential drug interactions (466/887 prescriptions). Most common pair causing pDDI was aspirin with losartan (4 %, n = 1376). CONCLUSION: Atorvastatin was the most frequently prescribed substance. Fifteen percent of the prescriptions originate from government sector. SLMC registration number and trade names were seen more in prescriptions originating from the private sector. Most prescriptions were legible with effort. NSAIDs were the commonest implicated in drug class duplication. Fifty three percent of prescriptions have pDDI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40360-016-0071-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4921016
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49210162016-06-26 Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka Rathish, Devarajan Bahini, Sivaswamy Sivakumar, Thanikai Thiranagama, Thilani Abarajithan, Tharmarajah Wijerathne, Buddhika Jayasumana, Channa Siribaddana, Sisira BMC Pharmacol Toxicol Research Article BACKGROUND: Prescription writing is a process which transfers the therapeutic message from the prescriber to the patient through the pharmacist. Prescribing errors, drug duplication and potential drug-drug interactions (pDDI) in prescriptions lead to medication error. Assessment of the above was made in prescriptions dispensed at State Pharmaceutical Corporation (SPC), Anuradhapura, Sri Lanka. METHODS: A cross sectional study was conducted. Drugs were classified according to the WHO anatomical, therapeutic chemical classification system. A three point Likert scale, a checklist and Medscape online drug interaction checker were used to assess legibility, completeness and pDDIs respectively. RESULTS: Thousand prescriptions were collected. Majority were hand written (99.8 %) and from the private sector (73 %). The most frequently prescribed substance and subgroup were atorvastatin (4 %, n = 3668) and proton pump inhibitors (7 %, n = 3668) respectively. Out of the substances prescribed from the government and private sectors, 59 and 50 % respectively were available in the national list of essential medicines, Sri Lanka. Patients address (5 %), Sri Lanka Medical Council (SLMC) registration number (35 %), route (7 %), generic name (16 %), treatment symbol (48 %), diagnosis (41 %) and refill information (6 %) were seen in less than half of the prescriptions. Most were legible with effort (65 %) and illegibility was seen in 9 %. There was significant difference in omission and/or errors of generic name (P = 0.000), dose (P = 0.000), SLMC registration number (P = 0.000), and in evidence of pDDI (P = 0.009) with regards to the sector of prescribing. The commonest subgroup involved in duplication was non-steroidal anti-inflammatory drugs (NSAIDs) (43 %; 56/130). There were 1376 potential drug interactions (466/887 prescriptions). Most common pair causing pDDI was aspirin with losartan (4 %, n = 1376). CONCLUSION: Atorvastatin was the most frequently prescribed substance. Fifteen percent of the prescriptions originate from government sector. SLMC registration number and trade names were seen more in prescriptions originating from the private sector. Most prescriptions were legible with effort. NSAIDs were the commonest implicated in drug class duplication. Fifty three percent of prescriptions have pDDI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40360-016-0071-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-25 /pmc/articles/PMC4921016/ /pubmed/27342193 http://dx.doi.org/10.1186/s40360-016-0071-z Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rathish, Devarajan
Bahini, Sivaswamy
Sivakumar, Thanikai
Thiranagama, Thilani
Abarajithan, Tharmarajah
Wijerathne, Buddhika
Jayasumana, Channa
Siribaddana, Sisira
Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
title Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
title_full Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
title_fullStr Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
title_full_unstemmed Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
title_short Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka
title_sort drug utilization, prescription errors and potential drug-drug interactions: an experience in rural sri lanka
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921016/
https://www.ncbi.nlm.nih.gov/pubmed/27342193
http://dx.doi.org/10.1186/s40360-016-0071-z
work_keys_str_mv AT rathishdevarajan drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT bahinisivaswamy drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT sivakumarthanikai drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT thiranagamathilani drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT abarajithantharmarajah drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT wijerathnebuddhika drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT jayasumanachanna drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka
AT siribaddanasisira drugutilizationprescriptionerrorsandpotentialdrugdruginteractionsanexperienceinruralsrilanka